These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 6419743)
1. Differences in UDP-glucuronosyltransferase activities in congenic inbred rats homozygous and heterozygous for the jaundice locus. Mackenzie PI; Owens IS Biochem Pharmacol; 1983 Dec; 32(24):3777-81. PubMed ID: 6419743 [TBL] [Abstract][Full Text] [Related]
2. Biotransformation and toxicity of acetaminophen in congenic RHA rats with or without a hereditary deficiency in bilirubin UDP-glucuronosyltransferase. de Morais SM; Chow SY; Wells PG Toxicol Appl Pharmacol; 1992 Nov; 117(1):81-7. PubMed ID: 1440617 [TBL] [Abstract][Full Text] [Related]
3. Potential genoprotective role for UDP-glucuronosyltransferases in chemical carcinogenesis: initiation of micronuclei by benzo(a)pyrene and benzo(e)pyrene in UDP-glucuronosyltransferase-deficient cultured rat skin fibroblasts. Vienneau DS; DeBoni U; Wells PG Cancer Res; 1995 Mar; 55(5):1045-51. PubMed ID: 7866987 [TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo biotransformation and covalent binding of benzo(a)pyrene in Gunn and RHA rats with a genetic deficiency in bilirubin uridine diphosphate-glucuronosyltransferase. Hu Z; Wells PG J Pharmacol Exp Ther; 1992 Oct; 263(1):334-42. PubMed ID: 1403794 [TBL] [Abstract][Full Text] [Related]
5. Modulation of benzo[a]pyrene bioactivation by glucuronidation in lymphocytes and hepatic microsomes from rats with a hereditary deficiency in bilirubin UDP-glucuronosyltransferase. Hu Z; Wells PG Toxicol Appl Pharmacol; 1994 Aug; 127(2):306-13. PubMed ID: 8048075 [TBL] [Abstract][Full Text] [Related]
6. Regioselectivity of rat liver microsomal UDP-glucuronosyltransferase activities toward phenols of benzo(a)pyrene and dibenz(a,h)anthracene. Lilienblum W; Platt KL; Schirmer G; Oesch F; Bock KW Mol Pharmacol; 1987 Jul; 32(1):173-7. PubMed ID: 3110592 [TBL] [Abstract][Full Text] [Related]
7. Induction of hepatic drug-metabolizing enzymes by cyclic fatty acid monomers in the rat. Siess MH; Vernevaut MF; Grandgirard A; Sébédio JL Food Chem Toxicol; 1988 Jan; 26(1):9-13. PubMed ID: 3126120 [TBL] [Abstract][Full Text] [Related]
8. A difference in mortality between two strains of jaundiced rats. Stobie PE; Hansen CT; Hailey JR; Levine RL Pediatrics; 1991 Jan; 87(1):88-93. PubMed ID: 1898623 [TBL] [Abstract][Full Text] [Related]
9. Induction of UDP-glucuronosyltransferase activities in Gunn, heterozygous, and Wistar rat livers by pregnenolone-16 alpha-carbonitrile. Watkins JB; Klaassen CD Drug Metab Dispos; 1982; 10(6):590-4. PubMed ID: 6130905 [TBL] [Abstract][Full Text] [Related]
10. Diabetes in female rats; changes in liver microsomal aminopyrine N-demethylase and UDP-glucuronyl transferase activities. Del Villar E; Vega P; Gaule C; Sanchez E Eur J Drug Metab Pharmacokinet; 1990; 15(4):279-85. PubMed ID: 2128478 [TBL] [Abstract][Full Text] [Related]
11. Hepatic oxidative drug metabolism and the microsomal milieu in a rat model of congenital hyperbilirubinemia. Meredith CG; Muhoberac BB; Gray JP; Speeg KV; Dunn D; Hoyumpa AM; Schenker S Biochem Pharmacol; 1986 Nov; 35(21):3831-7. PubMed ID: 3778508 [TBL] [Abstract][Full Text] [Related]
12. Differential action of thyroid hormones and chemically related compounds on the activity of UDP-glucuronosyltransferases and cytochrome P-450 isozymes in rat liver. Goudonnet H; Magdalou J; Mounie J; Naoumi A; Viriot ML; Escousse A; Siest G; Truchot R Biochim Biophys Acta; 1990 Jul; 1035(1):12-9. PubMed ID: 2116906 [TBL] [Abstract][Full Text] [Related]
13. Congenital jaundice in rats due to the absence of hepatic bilirubin UDP-glucuronyltransferase enzyme protein. Scragg I; Celier C; Burchell B FEBS Lett; 1985 Apr; 183(1):37-42. PubMed ID: 3920080 [TBL] [Abstract][Full Text] [Related]
14. Increase in a specific cytochrome P-450 isoenzyme in the liver of congenitally jaundiced Gunn rats. Kapitulnik J; Hardwick JP; Ostrow JD; Webster CC; Park SS; Gelboin HV Biochem J; 1987 Feb; 242(1):297-300. PubMed ID: 3593244 [TBL] [Abstract][Full Text] [Related]
15. [Studies on correlation between liver drug metabolizing enzyme activities and microsomal membrane fluidity in phenobarbital treated rats]. Fu LS; Peng RX Yao Xue Xue Bao; 1991; 26(8):567-71. PubMed ID: 1805518 [TBL] [Abstract][Full Text] [Related]
16. Isolation of multiple normal and functionally defective forms of uridine diphosphate-glucuronosyltransferase from inbred Gunn rats. Roy Chowdhury N; Gross F; Moscioni AD; Kram M; Arias IM; Roy Chowdhury J J Clin Invest; 1987 Feb; 79(2):327-34. PubMed ID: 3100574 [TBL] [Abstract][Full Text] [Related]
17. Glucuronide formation of various drugs in liver microsomes and in isolated hepatocytes from phenobarbital- and 3-methylcholanthrene-treated rats. Ullrich D; Bock KW Biochem Pharmacol; 1984 Jan; 33(1):97-101. PubMed ID: 6422942 [TBL] [Abstract][Full Text] [Related]
18. Hepatic microsomal composition studies in the Gunn rat. Gourley GR; Mogilevsky W; Odell GB Biochim Biophys Acta; 1983 Feb; 750(2):419-23. PubMed ID: 6860693 [TBL] [Abstract][Full Text] [Related]
19. Gene therapy with bilirubin-UDP-glucuronosyltransferase in the Gunn rat model of Crigler-Najjar syndrome type 1. Li Q; Murphree SS; Willer SS; Bolli R; French BA Hum Gene Ther; 1998 Mar; 9(4):497-505. PubMed ID: 9525311 [TBL] [Abstract][Full Text] [Related]
20. Preservation of various microsomal drug metabolizing components in tissue preparations from the livers, lungs, and small intestines of rodents. Tredger JM; Chhabra RS Drug Metab Dispos; 1976; 4(5):451-9. PubMed ID: 10144 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]